GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silva Pharmaceuticals Ltd (DHA:SILVAPHL) » Definitions » Additional Paid-In Capital

Silva Pharmaceuticals (DHA:SILVAPHL) Additional Paid-In Capital : BDT0.00 Mil(As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Silva Pharmaceuticals Additional Paid-In Capital?



Silva Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for Silva Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silva Pharmaceuticals Additional Paid-In Capital Chart

Silva Pharmaceuticals Annual Data
Trend
Additional Paid-In Capital

Silva Pharmaceuticals Semi-Annual Data
Additional Paid-In Capital

Silva Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Silva Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Silva Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Silva Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Road No 8/A New, House No 65, Dhanmondi, Dhaka, BGD, 1209
Silva Pharmaceuticals Ltd is engaged in the manufacturing and marketing of pharmaceuticals finished products. The products are manufactured in the categories of Antibiotics, Analgesics, Antidiabetics, Narcotics, Anti pyretic, Antiinflammatory Drugs, Anti ulcerates, Antiemetic, Gastroprokinetic, Antihistamine, Antispasmodic expectorants, Vitamins, and Minerals medicines. The products are sold in the local market of Bangladesh.

Silva Pharmaceuticals Headlines

No Headlines